BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會


BRIM Biotech


Company Info

Name /BRIM Biotech

Address /No. 1, Alley 30, Lan3 358, Ruiguang Rd., Neihu Dict., Taipei 11492, Taiwan

Website /


Name /Yi-chun Maria Chen

Title /VP of Scientific Operations and R&D

Email /

Telephone /(Work) 02 2659 8586#120

Fax /

Mobile /

Company Type


About the Company

BRIM is a new drug biotechnology company. We source first-in-class drugs globally with our experienced team for candidates at pre-clinical stage. Then, we develop projects by collaborating with top CROs and CMOs. Once clinical proof of concept (POC) is reached, we partner out our projects for further clinical development.

Brief Description of main products or services

BRM421 is a first-in-class, novel neurotrophic peptide drug for dry eye syndrome. BRIM completed its second-in-human Phase 2/3 trial in Q32020. Key clinical findings of the completed Ph2/3 trial:

A) Early onset: BRM421 shows efficacy in 2 weeks while current approved drug need 3-6 months

B) Novel MoA: BRM421 has cornea repair functions while other approved drugs have either tear volume or anti-inflammation

C) Great safety: No patient withdraws due to AEs

Contact Person

Name /江宜倫

Email /

Phone /02 2659 8586#120